Growth Metrics

Tandem Diabetes Care (TNDM) Share-based Compensation Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 9.69%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 3.57%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -4.08%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 12.16%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 12.94%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 26.61%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 59.09%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 31.63%
10 Tandem Diabetes Care 1.31 Bn 739.55 Mn 136.79 Mn -38.56%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -38.56%
Dec 31, 2025 -28.60%
Sep 30, 2025 -19.56%
Jun 30, 2025 2.99%
Mar 31, 2025 15.65%
Dec 31, 2024 23.86%
Sep 30, 2024 26.71%
Jun 30, 2024 6.40%
Mar 31, 2024 3.99%
Dec 31, 2023 -6.96%
Sep 30, 2023 -6.72%
Jun 30, 2023 16.24%
Mar 31, 2023 17.03%
Dec 31, 2022 42.94%
Sep 30, 2022 41.37%
Jun 30, 2022 34.41%
Mar 31, 2022 39.88%
Dec 31, 2021 28.49%
Sep 30, 2021 22.53%
Jun 30, 2021 -8.79%
Mar 31, 2021 -18.39%
Dec 31, 2020 -28.78%
Sep 30, 2020 -25.50%
Jun 30, 2020 33.27%
Mar 31, 2020 61.33%
Dec 31, 2019 81.25%
Sep 30, 2019 80.66%
Jun 30, 2019 356.71%
Mar 31, 2019 725.00%
Dec 31, 2018 384.90%
Sep 30, 2018 298.70%
Jun 30, 2018 12.42%
Mar 31, 2018 -59.78%
Dec 31, 2017 -27.37%
Sep 30, 2017 -17.66%
Jun 30, 2017 -20.77%
Mar 31, 2017 5.86%
Dec 31, 2016 -5.15%
Sep 30, 2016 -2.42%
Jun 30, 2016 -7.09%
Mar 31, 2016 -25.79%
Dec 31, 2015 -21.81%
Sep 30, 2015 -20.53%
Jun 30, 2015 -7.67%
Mar 31, 2015 0.05%
Dec 31, 2014 38.67%
Sep 30, 2014 288.10%
Jun 30, 2014 500.51%
Mar 31, 2014 6,633.93%